e-learning
resources
Virtual 2020
Tuesday, 08.09.2020
When the lung gets stiff
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pro-con debate: Does it make sense to view rapidly progressive ILD as a distinct clinical entity? - CON
V. Cottin (Lyon, France)
Source:
Virtual Congress 2020 – When the lung gets stiff
Session:
When the lung gets stiff
Session type:
Journal session
Number:
4822
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Cottin (Lyon, France). Pro-con debate: Does it make sense to view rapidly progressive ILD as a distinct clinical entity? - CON. Virtual Congress 2020 – When the lung gets stiff
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Pro-con debate: Does it make sense to view rapidly progressive ILD as a distinct clinical entity? - PRO
Source: Virtual Congress 2020 – When the lung gets stiff
Year: 2020
IPF: a distinct clinical entity?
Source: International Congress 2017 – State of the art session: "Interstitial lung disease and pulmonary vascular diseases"
Year: 2017
Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance?
Source: Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020
Year: 2020
Making clinical sense of the explosion in biologics - which drug for which patient and why?
Source: International Congress 2019 – PG10 Severe asthma in adults: systematic assessment and biological treatment
Year: 2019
The pathogenesis of IPF: what is the latest paradigm?
Source: International Congress 2019 – New Horizons in The Treatment of Pulmonary Fibrosis
Year: 2019
Respirologists‘ perception versus patient reality: A Canadian perspective on COPD
Source: Annual Congress 2011 - Integrated care and telehealth in primary care
Year: 2011
The progressive fibrotic phenotype in ILDs: can it be reliably recognised at baseline evaluation?
Source: International Congress 2019 – Lumping and splitting of fibrotic interstitial lung diseases
Year: 2019
Facing the challenges of self-management in COPD: how do people adapt to the disease, its symptoms and resulting limitations?
Source: Eur Respir J 2005; 26: Suppl. 49, 310s
Year: 2005
Is our approach to basic research right? Pitfalls and successes: what is the way forward?
Source: ERS Research Seminar 2016
Year: 2016
What do we need from our patients? - the clinician's point of view
Source: International Congress 2014 – PG17 Lung cancer: the issue with the tissue
Year: 2014
Early diagnosis of COPD: myth or a true perspective
Source: Eur Respir Rev, 29 (158) 200131; 10.1183/16000617.0131-2020
Year: 2020
MDR-/XDR-TB: what are the unresolved problems in the clinical management?
Source: Annual Congress 2012 - PG7 TB and MDR-/XDR-TB: what is new in diagnosis, treatment and follow-up (TB PAN-NET)
Year: 2012
Non Specific Interstitial Pneumonia and features of connective tissue disease:what are the consequences of a different point of view?
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: mechanistic insights and prognostic markers
Year: 2018
Large trials, new knowledge: the changing face of COPD management
Source: Eur Respir J 2015; 45: 1692-1703
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept